Aldolase A promotes cell proliferation and cisplatin resistance via the EGFR pathway in gastric cancer.

American journal of translational research(2022)

Cited 0|Views2
No score
Abstract
In the EGFR signaling pathway, ADOLA boosted the proliferation and cisplatin resistance of GC cells, making it a viable GC therapeutic target.
More
Translated text
Key words
ALDOA,EGFR,cisplatin resistance,gastric cancer,proliferation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined